A Study to Evaluate the Appropriateness of the Voriconazole Dosing Regimen

NCT03760276 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Fungal Infection

Interventions

DRUG: Voriconazole Oral Product (Vfend®)

Sponsor

Seoul National University Hospital